U.S. markets closed

SenesTech, Inc. (SNES)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.7500+0.1500 (+9.37%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close1.6000
Bid1.6800 x 900
Ask1.7300 x 1200
Day's Range1.6800 - 3.2000
52 Week Range1.3200 - 16.1200
Avg. Volume357,531
Market Cap5.948M
Beta (5Y Monthly)1.55
PE Ratio (TTM)N/A
EPS (TTM)-5.4210
Earnings DateAug 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • SNES: California Anticoagulant Bill Passed!!
    Zacks Small Cap Research

    SNES: California Anticoagulant Bill Passed!!

    NASDAQ:SNES Potential catalyst for accelerating sales of ContraPest, an environmentally responsible product that could benefit from ban on other rodenticides We believe California legislation that was just signed on September 29, 2020, by Gov. Gavin Newsom could encourage the use of SenesTech, Inc. (NASDAQ:SNES) product, ContraPest. AB 1788 restricts the use of second generation rodenticides in

  • Zacks Small Cap Research

    SNES: Anticoagulant bill passed!

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT Gov. Gavin Newsom signed AB1788 on September 29, 2020 and it becomes effective Jan. 1 2021. There are a few, but important, differences, to the original bill. The bill as passed significantly restricts the use of second generation anticoagulant rodenticides, SGARs and applies “any wildlife habitat area.” This certainly applies

  • SenesTech Maps Out Plan for Increased Use of ContraPest® in Integrated Pest Management in California
    PR Newswire

    SenesTech Maps Out Plan for Increased Use of ContraPest® in Integrated Pest Management in California

    SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today confirmed that California's AB1788 has been signed by Gavin Newsom, California's Governor and will become law January 1, 2021. The California Ecosystems Protection Act of 2020 (the Bill) will prohibit the use of the four major Second Generation Anticoagulant Rodenticides (SGARs) commonly used in rodent pest control under many circumstances. SenesTech's ContraPest, an alternative and complementary non-lethal approach to managing rodents through fertility control, has been proven in the field to be an effective and sustainable component of integrated pest management (IPM), and may be increasingly used to replace the SGARs.